Home Applications 219622 Application 219622
Type NDA
Sponsor CHIESI FARMACEUTICI SPA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 TRIMBOW BECLOMETHASONE DIPROPIONATE, FORMOTEROL FUMARATE, AND GLYCOPYRROLATE AEROSOL;INHALATION 86MCG/4.9MCG/10.6MCG, 86MCG, 4.9MCG, 10.6MCG No No 002 TRIMBOW BECLOMETHASONE DIPROPIONATE, FORMOTEROL FUMARATE, AND GLYCOPYRROLATE AEROSOL;INHALATION 172MCG/4.9MCG/10.6MCG, 172MCG, 4.9MCG, 10.6MCG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N219622-001 TRIMBOW BECLOMETHASONE DIPROPIONATE; FORMOTEROL FUMARATE; GLYCOPYRROLATE 0.086MG/INH;0.0049MG/INH;0.0106MG/INH AEROSOL, METERED / INHALATION RLD 2026-05-14 N219622-002 TRIMBOW BECLOMETHASONE DIPROPIONATE; FORMOTEROL FUMARATE; GLYCOPYRROLATE 0.172MG/INH;0.0049MG/INH;0.0106MG/INH AEROSOL, METERED / INHALATION RLD 2026-05-14
Orange Book patents# Current patent rows page 1 of 1 · 12 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N219622-001 10159645 2030-12-23 U-4538 Drug product 2026-06-05 N219622-001 10806701 2030-12-23 Drug product 2026-06-05 N219622-001 11389401 2030-12-23 Drug product 2026-06-05 N219622-001 11590074 2030-12-23 U-4538 2026-06-05 N219622-001 12357568 2030-12-23 U-4538 Drug product 2026-06-05 N219622-001 10617638 2034-12-23 U-4538 Drug product 2026-06-05 N219622-002 10159645 2030-12-23 U-4538 Drug product 2026-06-05 N219622-002 10806701 2030-12-23 Drug product 2026-06-05 N219622-002 11389401 2030-12-23 Drug product 2026-06-05 N219622-002 11590074 2030-12-23 U-4538 2026-06-05 N219622-002 12357568 2030-12-23 U-4538 Drug product 2026-06-05 N219622-002 10617638 2034-12-23 U-4538 Drug product 2026-06-05
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N219622-001 NP 2029-05-14 N219622-002 NP 2029-05-14
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N219622-001 TRIMBOW 0.086MG/INH;0.0049MG/INH;0.0106MG/INH AEROSOL, METERED / INHALATION RLD 2026-05-14 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N219622-002 TRIMBOW 0.172MG/INH;0.0049MG/INH;0.0106MG/INH AEROSOL, METERED / INHALATION RLD 2026-05-14 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N219622-001 TRIMBOW 0.086MG/INH;0.0049MG/INH;0.0106MG/INH AEROSOL, METERED / INHALATION RLD 2026-05-14 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219622-002 TRIMBOW 0.172MG/INH;0.0049MG/INH;0.0106MG/INH AEROSOL, METERED / INHALATION RLD 2026-05-14 c2088c7a36db…2026-09-14 22:38:34 2026-08 N219622-001 TRIMBOW 0.086MG/INH;0.0049MG/INH;0.0106MG/INH AEROSOL, METERED / INHALATION RLD, RS 2026-05-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219622-002 TRIMBOW 0.172MG/INH;0.0049MG/INH;0.0106MG/INH AEROSOL, METERED / INHALATION RLD, RS 2026-05-14 84e616aacf4f…2026-08-18 06:07:40 2026-07 N219622-001 TRIMBOW 0.086MG/INH;0.0049MG/INH;0.0106MG/INH AEROSOL, METERED / INHALATION RLD, RS 2026-05-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219622-002 TRIMBOW 0.172MG/INH;0.0049MG/INH;0.0106MG/INH AEROSOL, METERED / INHALATION RLD, RS 2026-05-14 caaa826d4ba7…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219622-001 TRIMBOW 0.086MG/INH;0.0049MG/INH;0.0106MG/INH AEROSOL, METERED / INHALATION RLD, RS 2026-05-14 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219622-002 TRIMBOW 0.172MG/INH;0.0049MG/INH;0.0106MG/INH AEROSOL, METERED / INHALATION RLD, RS 2026-05-14 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 2 · 60 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N219622-001 10159645 2030-12-23 U-4538 Drug product 2026-06-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N219622-001 10806701 2030-12-23 Drug product 2026-06-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N219622-001 11389401 2030-12-23 Drug product 2026-06-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N219622-001 11590074 2030-12-23 U-4538 2026-06-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N219622-001 12357568 2030-12-23 U-4538 Drug product 2026-06-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N219622-001 10617638 2034-12-23 U-4538 Drug product 2026-06-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N219622-002 10159645 2030-12-23 U-4538 Drug product 2026-06-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N219622-002 10806701 2030-12-23 Drug product 2026-06-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N219622-002 11389401 2030-12-23 Drug product 2026-06-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N219622-002 11590074 2030-12-23 U-4538 2026-06-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N219622-002 12357568 2030-12-23 U-4538 Drug product 2026-06-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N219622-002 10617638 2034-12-23 U-4538 Drug product 2026-06-05 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N219622-001 10159645 2030-12-23 U-4538 Drug product 2026-06-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219622-001 10806701 2030-12-23 Drug product 2026-06-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219622-001 11389401 2030-12-23 Drug product 2026-06-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219622-001 11590074 2030-12-23 U-4538 2026-06-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219622-001 12357568 2030-12-23 U-4538 Drug product 2026-06-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219622-001 10617638 2034-12-23 U-4538 Drug product 2026-06-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219622-002 10159645 2030-12-23 U-4538 Drug product 2026-06-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219622-002 10806701 2030-12-23 Drug product 2026-06-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219622-002 11389401 2030-12-23 Drug product 2026-06-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219622-002 11590074 2030-12-23 U-4538 2026-06-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219622-002 12357568 2030-12-23 U-4538 Drug product 2026-06-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219622-002 10617638 2034-12-23 U-4538 Drug product 2026-06-05 c2088c7a36db…2026-09-14 22:38:34 2026-08 N219622-001 10159645 2030-12-23 U-4538 Drug product 2026-06-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219622-001 10806701 2030-12-23 Drug product 2026-06-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219622-001 11389401 2030-12-23 Drug product 2026-06-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219622-001 11590074 2030-12-23 U-4538 2026-06-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219622-001 12357568 2030-12-23 U-4538 Drug product 2026-06-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219622-001 10617638 2034-12-23 U-4538 Drug product 2026-06-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219622-002 10159645 2030-12-23 U-4538 Drug product 2026-06-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219622-002 10806701 2030-12-23 Drug product 2026-06-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219622-002 11389401 2030-12-23 Drug product 2026-06-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219622-002 11590074 2030-12-23 U-4538 2026-06-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219622-002 12357568 2030-12-23 U-4538 Drug product 2026-06-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219622-002 10617638 2034-12-23 U-4538 Drug product 2026-06-05 84e616aacf4f…2026-08-18 06:07:40 2026-07 N219622-001 10159645 2030-12-23 U-4538 Drug product 2026-06-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219622-001 10806701 2030-12-23 Drug product 2026-06-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219622-001 11389401 2030-12-23 Drug product 2026-06-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219622-001 11590074 2030-12-23 U-4538 2026-06-05 caaa826d4ba7…
Observed Orange Book exclusivity history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents# Document, Submission type, Date table Document Submission type Date 85972 ORIG 2026-05-19 85954 ORIG 2026-05-18